Impact of Anti-IL-5 Therapy (Mepolizumab) on Objective Acoustic Voice Parameters in Type 2 Chronic Rhinosinusitis With Nasal Polyps
- 29 July 2026
- journal article
- Published by Elsevier in Journal of Voice
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- The impact of tamoxifen treatment on voice parameters in premenopausal women with breast cancerEuropean Archives of Oto-Rhino-Laryngology, 2023
- Changes in Voice After Septoplasty: A Pilot StudyIndian Journal of Otolaryngology and Head & Neck Surgery, 2022
- Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil countJournal of Allergy and Clinical Immunology, 2022
- International consensus statement on allergy and rhinology: rhinosinusitis 2021International Forum of Allergy & Rhinology, 2020
- Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trialsJournal of Allergy and Clinical Immunology, 2020
- Voice outcomes after endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyposisThe Laryngoscope, 2018
- Is there a future for biologics in the management of chronic rhinosinusitis?International Forum of Allergy & Rhinology, 2016
- Changes in Acoustic Parameters of Voice After Endoscopic Sinus Surgery in Patients with Nasal PolyposisIndian Journal of Otolaryngology and Head & Neck Surgery, 2014
- The Effect of Medical Treatment on Voice Quality in Allergic RhinitisIndian Journal of Otolaryngology and Head & Neck Surgery, 2013
- Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthmaJournal of Allergy and Clinical Immunology, 2013